Inovio Pharmaceuticals (LTS:0A43) Common Stock : $0.04 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inovio Pharmaceuticals Common Stock?

Inovio Pharmaceuticals's quarterly common stock stayed the same from Jun. 2024 ($0.03 Mil) to Sep. 2024 ($0.03 Mil) but then increased from Sep. 2024 ($0.03 Mil) to Dec. 2024 ($0.04 Mil).

Inovio Pharmaceuticals's annual common stock increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.02 Mil) and increased from Dec. 2023 ($0.02 Mil) to Dec. 2024 ($0.04 Mil).

Inovio Pharmaceuticals Common Stock Historical Data

The historical data trend for Inovio Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Common Stock Chart

Inovio Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.19

0.22

0.02

0.04

Inovio Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															0.02	0.02	0.03	0.03	0.04

Inovio Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Inovio Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (LTS:0A43) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

INO:USA INO:Mexico GBM:Germany

Address

660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462

Website

https://www.inovio.com

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals Headlines

No Headlines